Convergent Ventures
Los Angeles, Ca 90025

www.convergentventures.com

As a member of the Convergent Ventures team, we are a venture capital firm focused on early-stage life science investment opportunities in Southern California.

Based in Los Angeles, we identify and capitalize on opportunities through our extensive network of contacts at academic and medical institutions within our region. Our goal is to build successful companies and generate substantial capital gains for our investors and the entrepreneurs we support.

Orfid Corporation
Pasadena, CA

www.orfid.com

Jonathan G. Lasch, Ph.D. is the Chairman of the Board, President and CEO of ORFID Corporation. ORFID Corporation is an emerging leader in the field of organic semiconductors and polymer-based RFID (radio frequency identification) devices. The company is developing an entirely new class of organic semiconductor materials and RFID applications that will find broad utility in a diverse range of industries. ORFID's technology will enable the development and production of revolutionary products, from flexible organic displays to implantable biosensors and "smart" packaging. The company's strong and growing intellectual property portfolio covers the production of RFID devices on flexible polymer substrates using hybrid ink-jet printing technology.

Cyrano Sciences, Inc.
Pasadena, CA

www.cyranosciences.com
Founded in 1997, Cyrano Sciences is an electronic nose and sensory information software company. The technological engine behind Cyrano is a proprietary sensing technology invented at the Caltech. Dr. Lasch served as Vice President of Business Development and first employee of the Company .

Materia, Inc.
Pasadena, CA

www.materia-inc.com
Co-founded in 1997 by Dr. Lasch, Materia has become a world leader in the development and commercialization of metathesis technology. Materia's proprietary technology, based on metathesis catalysts developed at the Caltech, can be utilized in the production of numerous high value-added products, including specialty chemicals, pharmaceutical intermediates and advanced materials.

Neurion Pharmaceuticals, Inc.
Los Angeles, CA

www.neurionpharma.com
Convergent co-founded Neurion in 2002 with top scientists from Caltech. Neurion uses advanced methodologies from chemistry and molecular neurobiology to develop and optimize new small molecules to treat diseases of the central nervous system. Dr. Lasch serves as CEO and President, Mr. Robbins as Chairman, Mr. Adams as CFO and Mr. Aldrich as Board Member .